Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 May, 2018 15:33 IST
Indoco Remedies gets 8 USFDA observations for its Goa unit
Source: IRIS | 14 Feb, 2018, 10.09AM
Comments  |  Post Comment

Indoco Remedies has informed that USFDA inspected its solid dosage plant in Goa (Unit I). At the end of the inspection, the plant has received 8 observations (483s). The filling indicates that all the observations are correctable and the company is in the process of preparing its response for the same.

Exports from Goa solid dosage plant constitute less than 10% of the Indoco’s total exports and less than 4% of the total sales.

Shares of the company declined Rs 6.45, or 2.33%, to trade at Rs 269.90. The total volume of shares traded was 7,323 at the BSE (9.59 a.m., Wednesday).





Indoco Remedies Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Ashok Leyland quarterly net surges 40% - 18-May-2018 16:38
Bank of Baroda enters into MoU with CCRL - 18-May-2018 16:31
Strides Shasun turns to loss in Jan-Mar quarter - 18-May-2018 15:32
Bajaj Auto quarterly net up 36.33% - 18-May-2018 15:24
3i Infotech Services forays into retail as new vertical - 18-May-2018 13:04
Shriram Transport Finance inks MoU with HPCL - 18-May-2018 12:49
Airtel, Amazon India join hands to introduce a range of affordable 4G smartphones - 18-May-2018 12:11
L&T Construction wins orders worth Rs 15.04 bn - 18-May-2018 10:12
Glenmark Pharmaceuticals updates on clinical study of GBR 830 - 18-May-2018 10:08
R-Jio, Screenz partner to provide entertainment-based interactive platform - 18-May-2018 10:03
Sun Pharma launches generic Welchol tablets in US - 18-May-2018 09:49
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer